| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:2836.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
From the Program in Integrative Cardiac Metabolism, Departments of Physiology and Biophysics (L.T.W., E.D.L.) and Medicine (Cardiology) (E.D.L.), University of Illinois at Chicago College of Medicine; and Cardiovascular Research Institute (R.K.K., A.B.K. S.F.V.), Department of Cell Biology and Molecular Medicine, UMDNJ-New Jersey Medical School, Newark. Dr Kudej is currently at Tufts University School of Veterinary Medicine, North Grafton, Mass.
Correspondence to E. Douglas Lewandowski, PhD, Program for Integrative Cardiac Metabolism, Department of Physiology & Biophysics, MC 901, University of Illinois College of Medicine, 835 S Wolcott Ave, Chicago, IL 60612. E-mail dougl{at}uic.edu
Background Previous studies have examined only acute effects of enhanced glucose oxidation on postischemic myocardium. The goal of the present study was to examine prolonged functional recovery subsequent to postischemic, intracoronary pyruvate dehydrogenase kinase inhibition with dichloroacetate (DCA) of stunned myocardium in conscious pigs.
Methods and Results Myocardial stunning was induced in conscious pigs by coronary stenosis, ie, 40% reduction of coronary blood flow for 90 minutes, followed by full reperfusion. After the initial peak, but during early reactive hyperemia (5 minutes of reperfusion), 1 hour of intracoronary infusion at 20% of measured coronary blood flow was begun using 20 mmol/L [2-13C]glucose without (n=4) or with (n=5) 20 mmol/L DCA. Coronary stenosis resulted in similar reduction in wall thickening in both untreated (-53±3% from 3.27±0.22 mm, n=9) and DCA (-51±3% from 3.08±0.15 mm, n=5) groups. During reperfusion, DCA increased glucose oxidation 10-fold. In the absence of DCA, myocardial stunning was observed; ie, wall thickening was reduced by 48±3% at 1 hour of reperfusion and did not fully recover for 48 hours. In contrast, in DCA pigs, myocardial stunning was ameliorated (P<0.05).
Conclusions Transient metabolic intervention within a clinically relevant time after ischemia eliminates myocardial stunning in conscious pigs during augmented carbohydrate oxidation and provides sustained benefits in contractile recovery.
Key Words: stunning, myocardial reperfusion ischemia glucose
This article has been cited by other articles:
![]() |
H.-Z. Zhou, R. A. Swanson, U. Simonis, X. Ma, G. Cecchini, and M. O. Gray Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H714 - H723. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Parang, B. Singh, and R. Arora Metabolic Modulators for Chronic Cardiac Ischemia Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4): 217 - 223. [Abstract] [PDF] |
||||
![]() |
E. N. Churchill, C. L. Murriel, C.-H. Chen, D. Mochly-Rosen, and L. I. Szweda Reperfusion-Induced Translocation of {delta}PKC to Cardiac Mitochondria Prevents Pyruvate Dehydrogenase Reactivation Circ. Res., July 8, 2005; 97(1): 78 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Portman, K. Qian, J. Krueger, and X.-H. Ning Direct action of T3 on phosphorylation potential in the sheep heart in vivo Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2484 - H2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Nikolaidis, A. Doverspike, T. Hentosz, L. Zourelias, Y.-T. Shen, D. Elahi, and R. P. Shannon Glucagon-Like Peptide-1 Limits Myocardial Stunning following Brief Coronary Occlusion and Reperfusion in Conscious Canines J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 303 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Simoes, S. Egert, S. Ziegler, M. Miyagawa, S. Reder, T. Lehner, N. Nguyen, M. J. Charron, and M. Schwaiger Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1690 - 1697. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kristo, Y. Yoshimura, J. Niu, B. J. Keith, R. M. Mentzer Jr., R. Bunger, and R. D. Lasley The intermediary metabolite pyruvate attenuates stunning and reduces infarct size in in vivo porcine myocardium Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H517 - H524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lloyd, C. Brocks, and J. C. Chatham Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H163 - H172. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |